Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: nanosynth to dump masks; Feedback trading ahead

1st Jun 2022 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Feedback PLC, up 18% at 0.74 pence, 12-month range 0.55p-1.37p. Says trading performance for its recently ended financial year will be materially ahead of market expectations. For the year that ended May 31, Feedback expects to report revenue that beats market expectations, following progress with its flagship product Bleepa and additional technology licence fees arising from its partnership with Imaging Engineering LLC. For the 2021 financial year, Feedback's revenue was GBP290,000.

----------

AIM - LOSERS

----------

Impax Asset Management Group PLC, down 11% at 722.00 pence each, 12-month range 684.00p-1,482.00p. Shares drop as its thematic Environmental Markets strategies underperformed their benchmarks in the latter half of the period. Impax reported GBP2.5 billion of net inflows in the six months to the end of March, reflected in new mandates and increased investments into existing accounts in North America, Europe and Asia-Pacific. Assets under management as at March 31 were GBP38.02 billion, up 2.2% from GBP37.21 billion at the end of September, and 27% higher from GBP30.00 billion the same date a year before. Although most of Impax's strategies performed strongly over the first three months of the period, in the latter half the trust's first half, Environmental Markets strategies lagged behind their benchmarks - with Water underperforming the MSCI All Country World Index by 5.5%, Sustainable Food by 5.7%, Leaders by 7.9%; and Specialists by 9.2%.

----------

nanosynth Group PLC, down 8.3% at 0.37 pence, 12-month range 0.25p-1.65p. Looks to change its strategy in regards to its antiviral mask business, as many countries relax their restrictions in response to the Covid-19 pandemic. As a result of the waning demand for surgical masks, company is currently testing the spraying of its nanoparticle technology, with the purpose of selling the solution directly instead of manufacturing the masks and applying the solution. Says existing stock of masks will be written off in the company's accounts due to the incremental cost of preparing existing stock for commercial sales.

----------

By Paul McGowan; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.


Related Shares:

FeedbackImpax Asset ManagementNNN.L
FTSE 100 Latest
Value8,511.32
Change-97.16